Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model. [electronic resource]
Producer: 20111014Description: 219-24 p. digitalISSN:- 1557-7732
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Bruch Membrane -- radiation effects
- Choroid -- drug effects
- Choroidal Neovascularization -- drug therapy
- Delayed-Action Preparations -- administration & dosage
- Disease Models, Animal
- Drug Compounding
- Fluorescein Angiography -- drug effects
- Intravitreal Injections
- Lactic Acid -- chemistry
- Laser Coagulation -- adverse effects
- Male
- Polyethylene Glycols -- chemistry
- Polyglycolic Acid -- chemistry
- Polylactic Acid-Polyglycolic Acid Copolymer
- Rats
- Rats, Inbred BN
- Severity of Illness Index
- Time Factors
- Vascular Endothelial Growth Factors -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.